Orgeron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Orgeron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Orgeron Today - Breaking & Trending Today

Geron (NASDAQ:GERN) Rating Lowered to Neutral at Robert W. Baird

Robert W. Baird lowered shares of Geron (NASDAQ:GERN – Free Report) from an outperform rating to a neutral rating in a report published on Tuesday, MarketBeat Ratings reports. The firm currently has $4.50 price objective on the biopharmaceutical company’s stock. Several other brokerages also recently commented on GERN. Needham & Company LLC restated a buy […] ....

Robertw Baird , Charles Schwab Investment Management Inc , Walleye Capital , Goldman Sachs Group , Needham Company , Vivo Capital , Geron Corporation , Free Report , Marketbeat Ratings , Moderate Buy , Get Free Report , Schwab Investment Management , Geron Daily , Nasdaq Gern ,

Geron (GERN) Q1 2024 Earnings Call Transcript

GERN earnings call for the period ending March 31, 2024. ....

Stephen Willey , John Scarlett , Tara Bancroft , Aaron Feingold , Andrew Grethlein , Kalpit Patel , Gil Blum , Faye Feller , Michelle Robertson , Gil Blum Needham , Kalpit Patelb Riley , Karin Johnson , Graig Suvannavejh Goldman Sachs , Joel Beatty , Bristol Myers Squibb , Data Monitoring Committee , Geron Corporation , Corporate Communications , Goldman Sachs , Tuuli Tsogtbaatar Stifel Financial Corp , Company Analyst , Oncology Drugs Advisory Committee , Oncologic Drugs Advisory Committee , European Commission , Investor Relations , Anil Kapur ,

TD Cowen Initiates Coverage on Geron (NASDAQ:GERN)

TD Cowen started coverage on shares of Geron (NASDAQ:GERN – Free Report) in a research report sent to investors on Monday morning, MarketBeat reports. The firm issued a buy rating and a $10.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Wedbush reaffirmed an outperform […] ....

Needham Company , Geron Corporation , Pathstone Family Office , Goldman Sachs Group , Hermes Inc , Peaks Wealth Advisors , China Universal Asset Management Co , Sg Americas Securities , Free Report , Moderate Buy , Get Free Report , Family Office , Universal Asset Management , Twin Peaks Wealth Advisors , Geron Daily , Nasdaq Gern , Initiated Coverage , Td Cowen ,

Geron (GERN) to Release Earnings on Thursday

Geron (NASDAQ:GERN – Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Geron to post earnings of ($0.10) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Geron (NASDAQ:GERN – Get […] ....

Robertw Baird , Geron Corporation , Needham Company , Goldman Sachs Group , Get Free Report , Geron Daily , Nasdaq Gern ,

Geron (NASDAQ:GERN) Hits New 1-Year High at $4.05

Geron Co. (NASDAQ:GERN – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $4.05 and last traded at $4.01, with a volume of 6313886 shares traded. The stock had previously closed at $3.79. Analyst Upgrades and Downgrades A number of equities analysts recently […] ....

United States , Robertw Baird , Goldman Sachs Group , China Universal Asset Management Co , Vishria Bird Financial Group , Geron Corporation , Geron Company Profile , Moody National Bank Trust Division , Needham Company , Geron Co , Get Free Report , Bird Financial Group , National Bank Trust Division , Retirement System , China Universal Asset Management , Universal Asset Management , Geron Daily , Nasdaq Gern ,